Joseph M. Manko, Jr. became a director of the Company on June 27, 2019 when he was appointed by the board of directors to fill a vacancy on the board. Mr. Manko is the Managing Member and Senior Principal of Horton Capital Management, LLC, an investment manager, positions he has held since March 2013. Mr. Manko has also been a minority owner and a Managing Director at Mufson Howe Hunter & Co., LLC, a boutique investment bank focusing on middle-market companies, since June 2011. Prior to that, Mr. Manko was Partner and Chief Executive Officer of Switzerland-based BZ Fund Management Limited, where he was responsible for corporate finance, private equity investments, three public equity funds and the firm’s Special Situations and Event-Driven strategies, from January 2005 to December 2010. Mr. Manko was a Managing Director with Deutsche Bank AG, an investment bank in London, from September 1997 to December 2004. Earlier in his career, Mr. Manko served as a Vice President at Merrill Lynch & Co, Inc., an investment bank, from September 1995 until September 1997, and as a corporate finance attorney at Skadden, Arps, Slate, Meagher & Flom LLP, a law firm, from November 1991 until September 1995. Mr. Manko has served on the board of directors of Repro-Med Systems, Inc., a leading developer and manufacturer of medical devices and supplies, since May 2016 and as Lead Director since July 2018. Mr. Manko also served as a director of Safeguard Scientifics, Inc., a venture capital firm focused in healthcare, financial services and digital media, since March 2019. Mr. Manko has also served on the board of directors of Creative Realities, Inc., a marketing technology company from 2018-2020, and several European biotechnology companies, including NovImmune, S.A. from 2006 until 2010. Mr. Manko received his Juris Doctorate from the University of Pennsylvania Law School and his Bachelor’s degree from University of Pennsylvania. Mr. Manko’s experience on the boards of multiple public companies, his experience in the capital markets and public investing and his participation in numerous successful shareholder value creation strategies and monetizations qualify him to serve on the Company’s board of directors.